Last updated: 2026-09-16 01:10:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Gossamer Bio, Inc. (GOSS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $10.37, with a market capitalization of $65.57M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.10 to $309.60. This page covers its latest market performance, valuation, price trends and company information.
$65.57M | |
$10.61 | |
$2,171.98 | |
$9.10 | |
$10.70 | |
209.78K | |
346.19K | |
-- | |
$309.60 | |
$9.10 | |
-- | |
-- |
Gossamer Bio, Inc. (GOSS) last closed at $10.70 as of 2026-09-15 23:43:00, unchanged from the previous close of $10.70.
During the latest regular trading session, GOSS traded between $9.10 and $2,171.98, with a volume of 209.78K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Gossamer Bio, Inc. (GOSS) moved from $14.05 to $10.37, representing a decline of 26.18% ($3.68).
The stock traded between $10.07 and $14.75 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 217.26 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.4%
GOSS is currently trading at $10.37, placing it 0.4% of the way from its 52-week low of $9.10 to its 52-week high of $309.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 162 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Gossamer Bio, Inc. (GOSS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.